Company Filing History:
Years Active: 2017
Title: Ghislain Schyns: Innovator in Bioactive Molecules
Introduction
Ghislain Schyns is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of bioactive molecules, particularly in the development of fusion proteins that enhance feed utilization in animals. His innovative work has the potential to improve agricultural practices and animal nutrition.
Latest Patents
Ghislain Schyns holds a patent for the "Fusion of bioactive molecules." This patent describes fusion proteins containing an enzyme, preferably a feed or food enzyme, coupled to a gut surface-binding domain. These fusion proteins are designed to promote feed utilization in animals. A specific example of his invention includes a fusion enzyme that comprises a gut-surface-binding polypeptide segment linked to a phytase. This design increases the resident time in the gut, allowing the enzyme more time to catalyze the corresponding reaction, ultimately leading to improved feed utilization. He has 1 patent to his name.
Career Highlights
Ghislain Schyns is currently employed at Novozymes A/S, a company renowned for its focus on biological solutions. His work at Novozymes has allowed him to explore innovative approaches to enhance animal nutrition through biotechnological advancements.
Collaborations
Some of his notable coworkers include Stephane Duval and Aurelie Brelin. Their collaborative efforts contribute to the ongoing research and development in the field of bioactive molecules.
Conclusion
Ghislain Schyns is a pioneering inventor whose work in bioactive molecules is shaping the future of animal nutrition. His contributions through innovative patents and collaborations highlight the importance of biotechnology in agriculture.